Recent News

• 10.21.2025 - H.C. Wainwright Liver Disease Virtual Conference
• 10.21.2025 - H.C. Wainwright Liver Disease Virtual Conference
• 09.30.2025 - Stifel 2025 Virtual Cardiometabolic Forum
• 09.30.2025 - Stifel 2025 Virtual Cardiometabolic Forum
• 09.29.2025 - Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
• 09.29.2025 - Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
• 09.23.2025 - Altimmune to Participate in Two Upcoming Investor Conferences
• 09.23.2025 - Altimmune to Participate in Two Upcoming Investor Conferences

Recent Filings

• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.25.2025 - 8-K Current report